Transcenta Holding Limited (HKG:6628)
Hong Kong · Delayed Price · Currency is HKD 2.220
+0.110 (5.21%)
At close: Mar 6, 2026
Transcenta Holding Market Cap
Transcenta Holding has a market cap or net worth of 998.76 million as of March 6, 2026. Its market cap has increased by 263.34% in one year.
Market Cap
998.76M
Enterprise Value
1.18B
Revenue
10.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.22
Market Cap Chart
Since April 27, 2022, Transcenta Holding's market cap has decreased from 2.75B to 998.76M, a decrease of -63.74%. That is a compound annual growth rate of -23.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 998.76M | 4.72% |
| Dec 31, 2025 | 953.77M | 274.36% |
| Dec 31, 2024 | 254.77M | -82.96% |
| Dec 29, 2023 | 1.50B | 14.88% |
| Dec 30, 2022 | 1.30B | -52.74% |
| Apr 27, 2022 | 2.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CANbridge Pharmaceuticals | 1.40B |
| Beijing Biostar Pharmaceuticals | 1.33B |
| Kintor Pharmaceutical | 1.26B |
| Shanghai Bio-heart Biological Technology | 1.13B |
| Wuhan YZY Biopharma | 1.10B |
| HighTide Therapeutics | 1.09B |
| Brii Biosciences | 995.72M |
| Sunho Biologics | 971.95M |